GSEA analysis of ccRCC patient tumors suggests that low METTL3 expression levels may be related to some critical biological processes, such as the mTOR pathway, adipogenesis, and reactive oxygen species (ROS), which partially validates the RCC cell line results. This evidence concerns the gene MTOR and nonpapillary renal cell carcinoma.